Plain-English translation of NCT05001945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial studied MLS-101, a new medication designed to help people whose high blood pressure was not responding well to their current treatment. Researchers tested different doses of the medication to see if it was safe and effective at lowering blood pressure. The study compared the new treatment to a placebo (a dummy pill with no active ingredient) to understand how well the medication actually worked.
High blood pressure that doesn't respond to standard medications is a serious problem for many patients and increases their risk of heart disease and stroke. This trial was designed to find out whether this new treatment could offer another option for people who need better blood pressure control.
Participants received either the new medication or a placebo pill to take by mouth once or twice daily, depending on which group they were assigned to. The trial had two parts: in the first part, researchers tested different doses to find the right strength, and in the second part, they studied the best dose that was found. Throughout the trial, participants had their blood pressure monitored and had blood tests to make sure the treatment was safe.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States